Shares of digital advertising platform Cardlytics (NASDAQ:CDLX) have been on a tear lately, posting a more than 80% rise over the past five trading sessions.
The company recently boosted its first-quarter guidance. It now expects revenue to hover between $63.5 million and $66.5 million versus the earlier outlook between $54 million and $63 million.
Moreover, adjusted EBITDA loss is now anticipated between $8 million and $5 million. In comparison, CDLX had earlier guided for an Adjusted EBITDA loss between $17 million and $10 million.
Investors have been impressed with the Q1 revised guide and the company’s transition to a product-led operating structure seems to be paying off. The company is slated to report first-quarter numbers on May 11 and is expected to incur a net loss per share of $0.85 for the period.
Overall, the Street has a $5.90 consensus price target on CDLX implying the stock may be fairly priced at the current level after the recent price run-up.
Read full Disclosure
